Conform Pharm
Latest round
- Series B
Last raised
- May 2025
Total raised
- Undisclosed
Investors
- 3
About Conform Pharm
Conform Pharm is a pharmaceutical development company located in Wuhan, China, founded in 2007. The company specializes in creating therapeutic solutions, particularly for children and ophthalmic conditions. Its founder has not been specified, and there is no indication of a parent company or subsidiaries., which operates under the name Conform Pharm, focuses on developing and commercializing pharmaceutical products, with particular emphasis on pediatric and ophthalmic therapies. Its leading product, He Meijia® (Propranolol Hydrochloride Oral Solution), is significant for treating conditions such as infantile hemangiomas in young patients. The company utilizes an advanced technical platform based on nanoformulation to enhance drug delivery methods, including oral, ocular, transdermal, and injectable applications. He Meijia® is marketed in China under an exclusive license agreement with Pierre-Fabre, allowing Kefu to develop and distribute this critical product., Ltd. primarily generates revenue from the sale of its proprietary pharmaceutical products, particularly He Meijia® (Propranolol Hydrochloride Oral Solution). It employs a direct-to-consumer sales model alongside partnerships with healthcare providers and pharmacies for product distribution. Transactions typically occur on a per-unit basis through prescriptions issued by healthcare practitioners, leading to retail purchases by patients. The company aims to introduce upcoming products focused on pediatric and ophthalmic therapies, although specific release dates have not been disclosed. In addition, Conform Pharm is strategizing to expand its market presence beyond its current operations, although targeted regions for expansion have not been specified.
Who invested in Conform Pharm
3 investors across 1 round
See all investors in Conform Pharm
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 21, 2025
Amount
Undisclosed
Investors
Questions about Conform Pharm
Who invested in Conform Pharm?
Conform Pharm has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Conform Pharm raised?
Conform Pharm has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Conform Pharm last raise money?
Conform Pharm's most recent round on record is a Series B, in May 2025.
What does Conform Pharm do?
Conform Pharm is a pharmaceutical development company located in Wuhan, China, founded in 2007.
Where is Conform Pharm headquartered?
Conform Pharm is headquartered in Wuhan, China.
Which VCs invest in companies like Conform Pharm?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Conform Pharm's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Conform Pharm? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.